↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Nisoli E, Tonello C, Landi M, Carruba MO (1996). „Functional studies of the first selective β3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes”. Mol. Pharmacol.49 (1): 7–14. PMID8569714.
↑Bellantuono V, Cassano G, Lippe C (August 2008). „The adrenergic receptor subtypes present in frog (Rana esculenta) skin”. Comp. Biochem. Physiol. C Toxicol. Pharmacol.148 (2): 160–4. DOI:10.1016/j.cbpc.2008.05.001. PMID18544474.
↑Rickenbacher A, Seiler R, Honegger U, Shaw SG, Balsiger BM (January 2008). „Role of beta1-, beta2-, and beta3-adrenoceptors in contractile hypersensitivity in a model of small bowel transplantation”. Surgery143 (1): 94–102. DOI:10.1016/j.surg.2007.06.034. PMID18154937.
↑Leblais V, Pourageaud F, Ivorra MD, Guibert C, Marthan R, Muller B (April 2004). „Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery”. J. Pharmacol. Exp. Ther.309 (1): 137–45. DOI:10.1124/jpet.103.061192. PMID14718590.